Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 4/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.48 |
| ▸ | NAAA | Q02083 | 2/20 | 0.45 |
| ▸ | DGKA | P23743 | 1/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | PAM | P19021 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | RECQL | P46063 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.40 |
| ▸ | POLM | Q9NP87 | 1/20 | 0.40 |
| ▸ | POLK | Q9UBT6 | 1/20 | 0.40 |
| ▸ | POLL | Q9UGP5 | 1/20 | 0.40 |
| ▸ | POLH | Q9Y253 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.40 |
| ▸ | NLRP3 | Q96P20 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11686307 | 0.98 | KMT2A (0.50) | KMT2ASMN1; SMN2NAAADGKAALOX15 | |
| SCHEMBL11685635 | 0.98 | KMT2A (0.50) | KMT2ASMN1; SMN2NAAADGKAALOX15 | |
| SCHEMBL1025347 | 0.98 | KMT2A (0.50) | KMT2ASMN1; SMN2NAAADGKAALOX15 | |
| SCHEMBL8990270 | 0.95 | KMT2A (0.45) | KMT2ASMN1; SMN2NAAADGKAALOX15 | |
| SCHEMBL2308841 | 0.95 | KMT2A (0.45) | KMT2ASMN1; SMN2NAAADGKAALOX15 | |
| SCHEMBL3252645 | 0.87 | ALDH1A1 (0.43) | KMT2ASMN1; SMN2ALOX15LMNAMEN1 | |
| SCHEMBL10483624 | 0.87 | NAAA (0.47) | KMT2ASMN1; SMN2NAAADGKAALOX15 | |
| SCHEMBL11801851 | 0.87 | NAAA (0.44) | KMT2ASMN1; SMN2NAAADGKAALOX15 | |
| SCHEMBL404170 | 0.79 | — | — | |
| SCHEMBL7117515 | 0.79 | TSHR (0.44) | KMT2ASMN1; SMN2NAAADGKALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 137 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220409526-A1 | COMPOUNDS AND IMPLANTS FOR TREATING OCULAR DISORDERS | RETINA FOUND OF THE SOUTHWEST (US) | 2022-12-29 | — | — | US | claimed |
| US-20220409526-A1 | COMPOUNDS AND IMPLANTS FOR TREATING OCULAR DISORDERS | RETINA FOUND OF THE SOUTHWEST (US) | 2022-12-29 | — | — | US | disclosed |
| CN-112741816-A | Novel colon drug delivery system | 江苏集萃新型药物制剂技术研究所有限公司 | 2021-05-04 | — | — | CN | disclosed |
| CN-111372950-A | VEGFR-antibody light chain fusion proteins | 免疫苏醒公司 | 2020-07-03 | — | — | CN | disclosed |
| CN-111214701-A | Implants for localized drug delivery and methods of use thereof | 加利福尼亚大学董事会 | 2020-06-02 | — | — | CN | disclosed |
| EP-2171021-B1 | USE OF A CONDUCTIVITY IMPROVER IN A HYDROCARBON COMPOSITION | INNOSPEC LTD (GB) | 2020-04-01 | — | — | EP | disclosed |
| CN-106573133-B | Implants for localized drug delivery and methods of use thereof | 加利福尼亚大学董事会 | 2020-03-03 | — | — | CN | disclosed |
| EP-2102317-B1 | ADDITIVE, FUEL COMPOSITION, METHOD AND USE | INNOSPEC LTD (GB) | 2018-10-17 | — | — | EP | disclosed |
| EP-1640438-B1 | Improvements in Fuel Oils | INFINEUM INT LTD (GB) | 2017-08-30 | — | — | EP | disclosed |
| US-8961622-B2 | Additives for improving the cold properties of fuel oils | CLARIANT FINANCE (BVI) LIMITED (VG) | 2015-02-24 | — | — | US | disclosed |
| EP-0721492-A1 | ADDITIVES AND FUEL COMPOSITIONS | EXXON CHEMICAL PATENTS INC. (US) | 1996-07-17 | — | — | EP | disclosed |
| WO-1996018707-A1 | FUEL OIL COMPOSITIONS | EXXON CHEMICAL PATENTS INC. (US) | 1996-06-20 | — | — | WO | disclosed |
| WO-1996018708-A1 | FUEL OIL COMPOSITIONS | EXXON CHEMICAL PATENTS INC. (US) | 1996-06-20 | — | — | WO | disclosed |
| WO-1996018706-A1 | FUEL OIL COMPOSITIONS | EXXON CHEMICAL PATENTS INC. (US) | 1996-06-20 | — | — | WO | disclosed |
| WO-1995033805-A1 | FUEL OIL COMPOSITIONS | EXXON CHEMICAL PATENTS INC. (US) | 1995-12-14 | — | — | WO | disclosed |
| WO-1995033021-A1 | OIL ADDITIVES AND COMPOSITIONS | EXXON CHEMICAL PATENTS INC. (US) | 1995-12-07 | — | — | WO | disclosed |
| EP-0648258-A1 | OIL ADDITIVES AND COMPOSITIONS. | EXXON CHEMICAL PATENTS INC (US) | 1995-04-19 | — | — | EP | disclosed |
| WO-1995003377-A1 | ADDITIVES AND FUEL COMPOSITIONS | EXXON CHEMICAL PATENTS INC. (US) | 1995-02-02 | — | — | WO | disclosed |
| WO-1994017159-A1 | OIL AND FUEL OIL COMPOSITIONS | EXXON CHEMICAL PATENTS INC. (US) | 1994-08-04 | — | — | WO | disclosed |
| WO-1994000386-A1 | OIL ADDITIVES AND COMPOSITIONS | EXXON CHEMICAL PATENTS INC. (US) | 1994-01-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220409526-A1 | COMPOUNDS AND IMPLANTS FOR TREATING OCULAR DISORDERS | PDE6C, STRA6, PDE6A | KMT2A 3986/4885SMN1; SMN2 2532/4885NAAA 4388/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.